胃腸切除犬における血中グルカゴン動態:-健常時における膵特異性グルカゴン抗体反応性腸管グルカゴンの存在と膵外グルカゴンの血糖維持作用について-
スポンサーリンク
概要
- 論文の詳細を見る
There have been many reports, using pancreatic specific glucagon-antibody "K30". Since some clearly stated that after pancreatectomy, plasma pancreatic glucagon levels increased, it has become a major problem whether, in the normal state, the gastrointestinal glucagon which react the pancreatic specific glucagon antibody is determined, or whether there is any physiological activity of the extrapancreatic glucagon on the blood sugar metabolism.<BR>The present study was designed to detect any increase in the gastrointestinal glucagon which react the pancreatic specific glucagon antibody in the normal state, and also to examine the function of the extrapancreatic glucagon on the blood sugar metabolism.<BR>Twenty healthy dogs, weighing from 10 to 12kg, were used. These dogs were operated on under Ketalar anesthesia. After insertion of polyethlene catheters into the femoral and axillar veins, tracheal catheters were intubated. Under additional Ravonal anesthesia, gastroenterectomy of these dogs was performed, resecting from the end of the esophagus to the end of the ampulla of the rectum with a midline abdominal incision. The pancreases of all the dogs were preserved almost intact. The bleeding volumes and packed cell volumes (PCV) were measured during this operation at ten minute intervals. At the end of this operation, which took one hour and a half, PCV decreased from 43% to 32% in each dog. The five control dogs were exsanguinated at 32% of PCV for one and a half hours and only laparotomy was performed as a sham-operation under Ketalar anesthesia.<BR>1) Immediately after surgery, Arginine was administered at the rate of 130mg/kg/min for 15 minutes to the five gastroenterectomized dogs and to the five dogs who had under-gone the Sham operation. Plasma glucagon immunoreactivity (GI) (measured using pancreatic specific glucagon-antibody "K30" (Unger, Texas)) rose from a mean baseline value of 115 ± 9pg/ml up to a mean peak value of 200 ± 9pg/ml at 10 minutes in the gastroenterectomized dogs, and also, in the control dogs, GI rose from a mean baseline value of 158 ± 16 pg/ml to a mean peak value of 300 ±25pg/ml at 15 minutes. Total GLI (measured using non-specific glucagon-antibody "K4023" (Novo, Denmark)) increased from a mean baseline value of 130 ±14pg/ml to a mean peak value of 220 ±18pg/ml at 15 minutes in the gastroenterectomized. dogs, and also, in the control dogs, total GLI increased from a mean baseline value of 330 ±13pg/ml to a mean peak value of 705 ±62pg/ml at 10 minutes. IRI (measured by the two-antibody method) rose from a mean baseline value of 13 ±2μU/ml to a mean peak value of 46 ±812U/ml at 15 minutes in the gastroenterectomized dogs, and also, in the control dogs, IRI rose from a mean baseline value of 16 ±4/.2U/ml to a mean peak value of 32 ±3μU/ml. Blood sugar levels (BS) (measured by the glucose oxidase method) decreased from 152±2mg/dl to a mean trough value of 127 ±4mg/dl at 15 minutes in the gastroenterectomized dogs, but showed little change in the control dogs.<BR>2) At 2 hours after surgery, Arginine was administered at the same rate and the same volume as that at just after surgery to the five gastroenterectomized dogs and the five control dogs. There was no remarkable difference between the responses of GI, total GLI, IRI and BS to that at 2 hours after surgery and those responses at just after surgery.<BR>GI responses in arginine experiments showed significantly lower values at any point in the gastroenterectomized dogs than those in the control dogs (with the Student's t-test P<0.05). There was no significant difference between the response of GI and that of total GLI in the arginine experiments in the gastroenterectomized dogs at any point. Also IRI response showed no significant difference between the gastroenterectomized dogs and the control dogs.
- 日本内分泌学会の論文
著者
関連論文
- カフェインの心拍数並びに不整脈に及ぼす効果 : 日本循環器学会第72回近畿地方会
- 肝膿瘍, 細菌性腹膜炎, 膿胸の発症機序として bacterial translocation の関与が考えられた糖尿病患者の1例
- イヌにおける選択的β3アドレナリン作動薬の抗肥満効果 : (II)イヌβ3アドレナリン作動薬の慢性投与による褐色脂肪細胞の増加と体脂肪の減少
- イヌにおける選択的β3アドレナリン作動薬の抗肥満効果 : (I)イヌβ3アドレナリン受容体の発現とその作動薬によるin vivoでの脂肪動員
- 糖尿病教育ワークショップが糖尿病医療スタッフの意識や態度に与える影響について
- β_3-AR遺伝子多型における減量後の追跡調査
- 食事・運動療法とβ_3-AR遺伝子多型における食行動の認知的変容
- 両掌間誘導BI(bioelectrical impedance)法による体脂肪測定器の開発
- マウスにおいてβ3-アドレナリン作動薬は骨格筋の脱共役蛋白質発現を誘導する
- 地域における糖尿病対策の新たな展開 - プリシード・プロシードモデルの応用 -
- 両掌間誘導BI法体脂肪計の健診スクリーニング指標としての有用性検討
- S-4 耐糖能異常合併肥満症患者に対する防風通聖散のインスリン抵抗性改善効果
- グループワークやロールプレイを用いた糖尿病教室-患者のやる気・問題解決能力を引き出す技法-
- 肥満女性の体力とβ_3-アドレナリン受容体遺伝子多型の関係
- 5.肥満関連遺伝子情報が健康体力水準に及ぼす影響(第122回日本体力医学会関東地方会)
- Acanthosis nigricansと著明な高インスリン血症を呈した肥満の1例 -高脂肪食摂取とβ_3アドレナリン受容体ミスセンス変異の関与-
- 肥満型糖尿病女性患者に対するストレスマネージメント併用療法の意義
- 防風通聖散の抗肥満作用機序解明に関する基礎的研究 : MSG肥満マウスの褐色脂肪組織活性化作用について
- β_3受容体作働薬CL316,243の存在部位別にみたラット白色脂肪細胞の脂肪分解能
- 抗肥満作用を有するβ3アドレナリン受容体の脂肪組織でのUp-regulation : 動物
- カテコールアミン受容体とインスリン抵抗性
- 肥満における遺伝子多型の臨床的意義
- 管理栄養士に知ってほしい日本人肥満者の特徴と病態及び治療法
- 肥満を伴う2型糖尿病患者における軽度レジスタンス運動のインスリン抵抗性改善効果について
- 胃腸切除犬における血中グルカゴン動態:-健常時における膵特異性グルカゴン抗体反応性腸管グルカゴンの存在と膵外グルカゴンの血糖維持作用について-
- SomatostatinのInsulinおよびGlucagon分泌抑制作用に関する実験的研究:-Somatostatin投与時の末梢血IRI及びIRGの変化について-
- 我糖尿病外来における13年間の観察
- 糖尿病性昏睡と甲状腺クリーゼの合併例
- 糖尿病患者の血糖, IRI, GH及びNEFAに及ぼすMaltose静脈内持続投与の影響
- 静脈内ブドウ糖持続負荷試験について
- 交感神経活動の調節機構解明に関する研究:視床下部性肥満マウスを用いての検討
- 腸管グルカゴンに及ぼす下垂体の影響